Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Adams

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
EMBO Molecular Medicine|April 1, 2026
Tomatidine is a senotherapeutic compound that improves cognitive function and reduces cellular senescence in aged miceDaniela G Costa, Lucy M Gee, Gung Lee, et al.
Elife|May 4, 2021
OPA1 deletion in brown adipose tissue improves thermoregulation and systemic metabolism via FGF21Renata O Pereira, Alex Marti, Angela Crystal Olvera, et al.
Journal of Medicinal Chemistry|May 9, 2015
Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 InhibitorsJulien P N Papillon, Christopher M Adams, Qi-Ying Hu, et al.
Human Molecular Genetics|August 9, 2022
Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degenerationMaura A Crowley, Donita L Garland, Holger Sellner, et al.
JCI Insight|October 10, 2023
GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscleGeorge R Marcotte, Matthew J Miller, Hawley E Kunz, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Circulation|September 23, 2017
Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial HypertensionToshie Saito, Kazuya Miyagawa, Shih-Yu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2019
Small-molecule factor B inhibitor for the treatment of complement-mediated diseasesAnna Schubart, Karen Anderson, Nello Mainolfi, et al.
Journal of Medicinal Chemistry|February 20, 2020
Discovery of 4-((2<i>S</i>,4<i>S</i>)-4-Ethoxy-1-((5-methoxy-7-methyl-1<i>H</i>-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated DiseasesNello Mainolfi, Takeru Ehara, Rajeshri G Karki, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
EMBO Molecular Medicine|April 1, 2026
Tomatidine is a senotherapeutic compound that improves cognitive function and reduces cellular senescence in aged miceDaniela G Costa, Lucy M Gee, Gung Lee, et al.
Elife|May 4, 2021
OPA1 deletion in brown adipose tissue improves thermoregulation and systemic metabolism via FGF21Renata O Pereira, Alex Marti, Angela Crystal Olvera, et al.
Journal of Medicinal Chemistry|May 9, 2015
Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 InhibitorsJulien P N Papillon, Christopher M Adams, Qi-Ying Hu, et al.
Human Molecular Genetics|August 9, 2022
Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degenerationMaura A Crowley, Donita L Garland, Holger Sellner, et al.
JCI Insight|October 10, 2023
GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscleGeorge R Marcotte, Matthew J Miller, Hawley E Kunz, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Circulation|September 23, 2017
Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial HypertensionToshie Saito, Kazuya Miyagawa, Shih-Yu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2019
Small-molecule factor B inhibitor for the treatment of complement-mediated diseasesAnna Schubart, Karen Anderson, Nello Mainolfi, et al.
Journal of Medicinal Chemistry|February 20, 2020
Discovery of 4-((2<i>S</i>,4<i>S</i>)-4-Ethoxy-1-((5-methoxy-7-methyl-1<i>H</i>-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated DiseasesNello Mainolfi, Takeru Ehara, Rajeshri G Karki, et al.
Pageof 13